J&J CEO: We Could Cure Some Cancers Within 10 Years

Johnson & Johnson's CEO said on June 10, 2026, that curing certain cancers—or turning others into manageable long-term diseases—is scientifically achievable within a decade. The company is testing new treatments for multiple myeloma and lung cancer. The claim matters because it shapes investor expectations, though whether the clinical evidence actually backs a decade-long timeline remains an open question.